IRHYTHM TECHNOLOGIES BUSINESS MODEL CANVAS TEMPLATE RESEARCH B_187 R&D expenses for 2023 were

R&D expenses for 2023 were about $250 million

Regional Partners

18% higher conversion)

80% of users reported no noticeable performance impact

CySEC (EU) and MAS (Singapore) as strategic partners to preserve its no‑last‑look

IRHYTHM TECHNOLOGIES BUSINESS MODEL CANVAS TEMPLATE RESEARCH B_187 R&D expenses for 2023 wereiRhythm's Blueprint: Remote Cardiac Monitoring, Subscriptions, Clinician Growth Unlock the full strategic blueprint behind iRhythm Technologies's business model in a concise, actionable format see how remote cardiac monitoring, subscription revenue, and clinician partnerships drive growth and margins. Partnerships 1,200 Integrated Delivery Networks and Health Systems iRhythm Technologies has embedded its Zio service across 1,200 US integrated delivery